Loading ...NanoBio Successfully Completes Phase 2b Study in Herpes Labialis
Posted on March 17th, 2008 by Newton
NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis
Ann Arbor, Mich., March 17, 2008 - NanoBio Corporation reported top-level findings today from its phase 2b study of NB-001, a topical lotion to treat herpes labialis (cold sores). The randomized, double-blind, vehicle-controlled study met its primary and secondary endpoints by demonstrating clear efficacy and safety [.. more ..]
Filed under: High Tech | No Comments »
